The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
|Articles|April 7, 2020
Don’t Miss! April 16 Webcast: COVID-19 and the Dietary Supplement Supply Chain
How will the coronavirus pandemic impact dietary supplement manufacturing? In this webcast, Nutritional Outlook’s editors check in with industry experts and global suppliers to get an update on current and future challenges in their countries.FREE to attend!Register now: https://www.nutritionaloutlook.com/no/covid19
Advertisement
How will the coronavirus pandemic impact dietary supplement manufacturing? In this webcast, Nutritional Outlook’s editors check in with industry experts and global suppliers to get an update on current and future challenges in their countries.
FREE to attend!
Register now:
Advertisement
Related to this article
Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
The four-formula line is Olly’s second retailer-exclusive launch this year, following the launch of a probiotic range in April.
The company’s new division offers bovine, porcine, ovine, poultry glandulars for supplements, pet food, and animal feed, highlighting a full QA document package.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
What Japan's Red Yeast Rice Crisis Teaches Ingredient Suppliers About FDA's New NDI Guidance
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panelists Outline Product Opportunities Tied to GLP-1 Medication Use
5